Mark Vossenaar

Mark Vossenaar currently serves as Vice President and General Manager of the Biopharmaceutical Development Division at Mesa Laboratories, Inc., following the acquisition of Gyros Protein Technologies. Vossenaar also contributes as an Advisory Board Member for Concord Neonatal, focusing on improving care for preterm babies, and for RWE Genesys, which aims to deliver translational insights for healthcare companies. As a co-founder and director of FOXpartnership, Vossenaar manages event management and consultancy services. Previously, Vossenaar founded Taruna Medical, connecting Med-Tech manufacturers with prospective customers, and held several leadership positions at Gyros Protein Technologies, Hill-Rom, Agilent Technologies, Stratagene, and GE Healthcare, developing marketing strategies and driving commercial performance across various life sciences sectors.